Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Lindberg

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Lakartidningen|June 27, 2002
[The LIFE study: extensive marketing in Denmark. Suggestions to conclusions based on the study]Mats Lindberg
Ugeskrift for Laeger|September 13, 2003
[Proton pump inhibitors--are they really harmless?]Mats Lindberg
Ugeskrift for Laeger|February 12, 2005
[New lower cholesterol levels--more debate]Mats Lindberg
Ugeskrift for Laeger|January 1, 2005
[New lower cholesterol levels: How much does it cost? Who is to pay?]Mats Lindberg
Ugeskrift for Laeger|September 27, 2008
[Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?]Mats Lindberg
Ugeskrift for Laeger|March 6, 2007
[Too positive comment on glitazones]Mats Lindberg
Ugeskrift for Laeger|September 10, 2002
[Osteoarthritis and COX-2 inhibitors]Mats Lindberg
Ugeskrift for Laeger|November 25, 2010
[Hasty dead certain conclusions about TNF inhibitors]Mats Lindberg
Ugeskrift for Laeger|October 9, 2003
[Does "commercial bias" exist?]Mats Lindberg
Ugeskrift for Laeger|October 29, 2003
[New thinking necessary?]Mats Lindberg
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Lakartidningen|June 27, 2002
[The LIFE study: extensive marketing in Denmark. Suggestions to conclusions based on the study]Mats Lindberg
Ugeskrift for Laeger|September 13, 2003
[Proton pump inhibitors--are they really harmless?]Mats Lindberg
Ugeskrift for Laeger|February 12, 2005
[New lower cholesterol levels--more debate]Mats Lindberg
Ugeskrift for Laeger|January 1, 2005
[New lower cholesterol levels: How much does it cost? Who is to pay?]Mats Lindberg
Ugeskrift for Laeger|September 27, 2008
[Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?]Mats Lindberg
Ugeskrift for Laeger|March 6, 2007
[Too positive comment on glitazones]Mats Lindberg
Ugeskrift for Laeger|September 10, 2002
[Osteoarthritis and COX-2 inhibitors]Mats Lindberg
Ugeskrift for Laeger|November 25, 2010
[Hasty dead certain conclusions about TNF inhibitors]Mats Lindberg
Ugeskrift for Laeger|October 9, 2003
[Does "commercial bias" exist?]Mats Lindberg
Ugeskrift for Laeger|October 29, 2003
[New thinking necessary?]Mats Lindberg
Pageof 5